To celebrate the Academy’s 20th birthday, we have put together a snapshot of 20 of our biggest impacts. To find out more about our 20th celebrations and our future plans, read this blog by our President Professor Sir Robert Lechler, and follow #AMS20 on social media.
The Academy would like to thank all our funders, partners and collaborators, without whom none of this work would be possible.
#18 Influencing in Europe and beyond
“Science is increasingly a global and collaborative sector, with researchers across the world working together to solve health challenges. The Academy has helped the UK’s voice to be heard on an international stage, as well as making worldwide links.
“In this current post-Brexit climate, it is even more apparent how medical science must work across borders. After we leave Europe we must continue to reach outwards, keeping close ties with Europe, and extending our efforts beyond. It is encouraging to see the Academy building relationships with their international counterparts, policymakers and researchers - a clear priority at this time.”
Professor George Griffin CBE FMedSci, President of the Federation of European Academies of Medicine
Throughout our history, the Academy has looked to make contacts and influence beyond the UK.
Since the UK referendum on leaving the European Union, we have been in constant contact with policy makers about how to safeguard biomedical research after Britain leaves the EU. Working with influential partners, we have produced an extensive array of statements, consultation responses and research, and we have held regular meetings with Ministers and senior officials. As a result, one of the Prime Minister’s objectives for a good outcome to Brexit negotiations is making Britain “the best place for science and innovation”.
We have worked alongside the Federation for European Academies of Medicine (FEAM) for many years. We helped FEAM to secure funding to recruit more staff and carry out a strategic review, in turn leveraging investment from other European medical academies. We worked together to ensure FEAM’s policy work on the EU Clinical Trials Directive in 2010 was informed by the UK position, and alerted decision makers to the potential negative impact of the EU Data Protection Regulation in 2015.
The Academy is also building ties beyond Europe, through recent joint meetings with the Japan Society for Promotion of Science and the InterAcademy Partnership for Health. In early 2019, the Academy will hold two milestone scientific meetings: a meeting with the US National Academy of Medicine to discuss how the behavioural sciences can improve health; and a UK-India meeting supported by the Hamied Foundation on the global challenge of antimicrobial resistance.